New protective antigen of group A streptococci

Journal of Clinical Investigation

Volumn 103, Issue 9, 1999, Pages 1261-1268

  Dale, James B ^a,b   Chiang, Edna Y ^a   Liu, Shaoyou ^a   Courtney, Harry S ^a,b   Hasty, David L ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOCOCCUS ANTIGEN; STREPTOCOCCUS VACCINE;

ANTIGEN RECOGNITION; ARTICLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

EID: 0033135117     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5118     Document Type: Article

References (32)

1. Fischetti, V.A. 1989. Streptococcal M protein: molecular design and biological behavior. Clin. Microbiol. Rev. 2:285-314.
2. Lancefield, R.C. 1962. Current knowledge of the type-specific M antigens of group A streptococci. J. Immunol. 89:307-313.
3. Caparon, M.G., and Scott, J.R. 1987. Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. Proc. Natl. Acad. Sci. USA. 84:8677-8681.
4. Hollingshead, S.K., Readdy, T.L., Yung, D.L, and Bessen, D.E. 1993. Structural heterogeneity of the emm gene cluster in group A streptococci. Mol. Microbiol. 8:707-717.
5. Perez-Casal, J., Caparon, M.G., and Scott, J.R. 1992. Introduction of the emm6 gene into and emm-deleted strain of Streptococcus pyogenes restores its ability to resist phagocytosis. Res. Microbiol. 143:549-558.
6. Courtney, H.S., Bronze, M.S., Dale, J.B., and Hasty, D.L. 1994. Analysis of the role of M24 protein in streptococcal adhesion and colonization by use of omega-interposon mutagenesis. Infect. Immun. 62:4858-4873.
7. Podbielski, A., Schnitzler, N., Beyhs, P., and Boyle, M.D.P. 1996. M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol. Microbiol. 19:429-441.
8. Dale, J.B., Washburn, R.G., Marques, M.B., and Wessels, M.R. 1996. Hyaluronate capsule and surface M protein in resistance to phagocytosis of group A streptococci. Inject. Immun. 64:1495-1501.
9. Wessels, M.R., Moses, A.E., Goldberg, J.B., and DiCesare, T.J. 1991. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. USA. 88:8317-8321.
10. Dale, J.B., Chiang, E.Y., and Lederer, J.W. 1993. Recombinant tetravalent group A streptococcal M protein vaccine. J. Immunol. 151:2188-2194.
11. Dale, J.B. and Beachey, E.H. 1986. Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein. J. Exp. Med. 163:1191-1202.
12. Sambrook J., Fritsch, E.F., and Maniatis, T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY.
13. Dale, J.B., and Beachey, E.H. 1985. Multiple, heart cross-reactive epitopes of streptococcal M proteins. J. Exp. Med. 161:113-122.
14. Moses, A.L., et al. 1997. Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A streptococcus. Infect. Immun. 65:64-71.
15. Chen, C., and Cleary, P.P. 1990. Complete nucleotide sequence of the C5a peptidase gene of Streptococcus pyogenes. J. Biol. Cbem. 265:3161-3167.
16. Beachey, E.H., et al. 1977. Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of the type 24 M antigen. J. Exp. Med. 145:1469-1481.
17. Reed, L.J., and Muench, H. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27:493-499.
18. Beachey, E.H., Campbell, G.L., and Ofek, I. 1974. Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin. Infect. Immun. 9:891-896.
19. Evans, D.J., Evans, D.G., Lampert, H.C., and Nakano, H. 1995. Identification of four new prokaryotic bacterioferritins from Helicobacter pylori, Anabaena variabilis, Bacillus subtilis and Treponema pallidum, by analysis of gene sequences. Gene. 153:123-127.
20. Zabriskie, J.B., and Freimer, E.H. 1966. An immunological relationship between the group A streptococcus and mammalian muscle. J. Exp. Med. 124:661-678.
21. Dale, J.B., Seyer, J.M., and Beachey, E.H. 1983. Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein. J. Exp. Med. 158:1727-1732.
22. Jones, K.F. and Fischetti, V.A., 1988. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci. J. Exp. Med. 167:1114-1123.
23. Dale, J.B., Simmons, M., Chiang, E.C., and Chiang, E.Y. 1996. Recombinant, octavalent group A streptococcal M protein vaccine. Vaccine. 14:944-948.
24. Dale, J.B. 1999. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Vaccine. 17:193-200.
25. Hirst, G.K., and Lancefield, R.C. 1939. Antigenic properties of the type-specific substances derived from group A hemolytic streptococci. J. Exp. Med. 69:425-438.
26. Wiley, G.G., and Wilson, A.T. 1960. The occurrence of two M antigens in certain group A streptococci related to type 14. J. Exp. Med. 113:451-460.
27. Wiley, G.G., and Bruno, P.N. 1968. Cross-reaction among group A streptococci. I. Precipitin and bactericidal cross-reactions among types 33, 41, 43, 52, and Ross. J. Exp. Med. 128:959-972.
28. Bergner-Rabinowitz, S., Ofek, I., and Moody, M.D. 1972. Cross-protection among serotypes of group A streptococci. J. Infect. Dis. 125:339-347.
29. Dale, J.B., and Beachey, E.H. 1984. Unique and common protective epitopes among different serotypes of group A streptococcal M proteins defined with hybridoma antibodies. Infect. Immun. 46:267-269.
30. Chappell, J.D., and Stuart, J.G. 1993. Demonstration of protection in mice from a lethal challenge of three M serotypes of Streptococcus pyogenes using an M-negative vaccine. Vaccine. 11:643-649.
31. Veasy, L.G., et al. 1987. Resurgence of acute rheumatic fever in the intermountain area of the United States. N. Engl. J. Med. 316:421-427.
32. Johnson, D.R., Stevens, D.L., and Kaplan, E.L. 1992. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J. Infect. Dis. 166:374-382.